Page 58 - Read Online
P. 58
Yagawa et al. Cancer immunity and hyperthermia
regard to biological effects are found until now. DECLARATIONS
Overall, hyperthermia is considered a convenient Authors’ contributions
therapeutic method so long as it is used appropriately. Designed and wrote the manuscripts: Y. Yagawa
Paradoxically, the safety of hyperthermia is maintained Conducted IFN-γ and IL-2 production assays: Y.
by avoiding excess irradiation with the purpose of deep Kobayashi
heating, because it is still difficult to aggregate the heat Provided suggestions on the revision of the
effect only in cancer tissue. By using hyperthermia manuscripts: M. Yamamoto
in combination with chemotherapy or radiotherapy, Built Figures 1, 4 and 5 and revised the manuscript:
the dose of these therapies may be reduced to ease K. Tanigawa
their side-effects without reducing therapeutic effects,
because hyperthermia has the potential to augment Financial support and sponsorship
the effect of chemotherapy or radiotherapy in a less None.
invasive manner.
Conflicts of interest
CONCLUSION There are no conflicts of interest.
Patient consent
This report shows that hyperthermia increases the Not applicable.
advantage of the following biological features. Heat
stress lowers the survival rate of all cells, but normal Ethics approval
tissues are better able to tolerate this than cancerous Not applicable.
tissues. Heat has a potential to augment immune
responses while decreasing immune suppression.
Heat inhibits the recovery of cancer cells from DNA REFERENCES
damage. Heat enhances the resorption of anticancer 1 Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J,
drugs into cancer cells. The sensitivity of cancer Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz
cells against heat and radiation differs depending A, McCombie WR, Hicks J, Wigler M. Tumour evolution inferred by
on the condition of cancer cells in the cell cycle. The single-cell sequencing. Nature 2011;472:90-4.
anticancer efficacy of hyperthermia alone with currently 2. Griffith KD, Read EJ, Carrasquillo JA, Carter CS, Yang JC, Fisher B,
available heating devices is not enough to suggest its Aebersold P, Packard BS, Yu MY, Rosenberg SA. In vivo distribution
use as a standalone therapy. However, some studies of adoptively transferred indium-111-labeled tumor infiltrating
lymphocytes and peripheral blood lymphocytes in patients with
have shown that combination therapy with conventional metastatic melanoma. J Natl Cancer Inst 1989;81:1709-17.
methods including immunotherapy, radiotherapy, 3. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA,
chemotherapy, and surgery improves its anticancer Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino
efficacy in vitro and vivo. MJ, Culver K, Dusty Miller A, Michael Blaese R, French Anderson
W. Gene transfer into humans--immunotherapy of patients with
Perspective advanced melanoma, using tumor-infiltrating lymphocytes modified
Currently, clinical experience and data of oncological 4. by retroviral gene transduction. N Engl J Med 1990;323:570-8.
Wolchok JD, Weber JS, Maio M, Neyns B, Harmankaya K, Chin K,
hyperthermia are still limited because both information Cykowski L, de Pril V, Humphrey R, Lebbé C. Four-year survival
and devices for hyperthermia have not become rates for patients with metastatic melanoma who received ipilimumab
common. Therefore, multicenter clinical trials for cancer in phase II clinical trials. Ann Oncol 2013;24:2174-80.
treatment including hyperthermia should be done to 5. Balar AV, Weber JS. PD-1 and PD-L1 antibodies in cancer:
provide convincing data. The combination hyperthermia current status and future directions. Cancer Immunol Immunother
with immune check-point inhibitors should be involved 2017;66:551-64.
in these studies to achieve fuller anticancer efficacy 6. Mackowiak PA. Concepts of fever. Arch Intern Med 1998;158:1870-
81.
with fewer adverse effects. Development of drugs 7. Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE. Cellular
such as DNA repair inhibitors or regulators of HSPs is responses to combinations of hyperthermia and radiation. Radiology
also expected to augment the efficacy of hyperthermia 1977;123:463-74.
itself. Additionally, further efforts will be required to 8. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes
solve the mechanism of the involvement of cancer PJ. Basic principles of thermal dosimetry and thermal thresholds for
and hyperthermia to optimize cancer therapy. The tissue damage from hyperthermia. Int J Hyperthermia 2003;19:267-
94.
development of heating devices and thermometry is 9. Hall EJ, Roizin-Towle L. Biological effects of heat. Cancer Res
also needed to achieve more appropriate heat delivery 1984;44:s4708-13.
that is limited to the tumor lesion. 10. Luk KH, Purser PR, Castro JR, Meyler TS, Phillips TL. Clinical
Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ October 31, 2017 227